NNRF, Inc./ US6293551080 /
03/06/2024 21:30:00 | Var. -0.0003 | Volume | Denaro- | Lettera- | Max | Min |
---|---|---|---|---|---|---|
0.0020USD | -11.11% | 125,000 Fatturato: 250 |
-Quantità in denaro: - | -Quantità in lettera: - | 0.0020 | 0.0020 |
GlobeNewswire
22:10
Applied Optoelectronics to Present at the Rosenblatt 4th Annual Technology Summit: The Age of AI
GlobeNewswire
22:10
TEN Ltd. Announces Completion of Viken Fleet Acquisition and Sale of Aframax Tanker and LNG Carrier
GlobeNewswire
22:10
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4...
GlobeNewswire
22:10
Locafy to Participate in the “Charting the Course: Navigating the Intersection of TMT and Business i...
GlobeNewswire
22:09
Structure Therapeutics Announces Proposed Public Offering of American Depositary Shares and Pre-Fund...
GlobeNewswire
22:07
SPROUT SOCIAL 40 DAY NOTICE: Investors of Sprout Social, Inc. (Nasdaq: SPT) are Encouraged to Contac...
GlobeNewswire
22:05
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
22:05
Kernel Group Holdings, Inc. Extends Period to Consummate Initial Business Combination
GlobeNewswire
22:05
FibroGen Announces Clinical Trial Supply Agreement with Regeneron Pharmaceuticals to Evaluate FibroG...
GlobeNewswire
22:05
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
22:05
Lyell Immunopharma to Participate in the Goldman Sachs Global Healthcare Conference
GlobeNewswire
22:05
SECURITIES FRAUD INVESTIGATION: Investors of CAE, Inc. (NYSE: CAE) Who Lost Money on Company Impairm...
GlobeNewswire
22:05
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
22:05
Genetics in Medicine Publishes Myriad Genetics Patient-Outcomes Study Validating RiskScore® as a Cli...